SCM
DGX icon

Sio Capital Management’s Quest Diagnostics DGX Stock Holding History

Sio Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-92,000
Closed -$14.4M – 46
2022
Q4 		$14.4M Buy
+92,000
New +$13.2M 5.32% 7

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sio Capital Management's DGX Position: Q4 2020 in Review

Sio Capital Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 75,000 shares — an estimated $8.59M sold.

Sio Capital Management first reported a position in DGX in Q3 2020 and held it in 1 quarter. The position peaked at $8.59M in Q3 2020. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Sio Capital Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Sio Capital Management sold 75,000 Quest Diagnostics shares in Q4 2020, an estimated $8.59M.
  • Sio Capital Management first reported a position in Quest Diagnostics in Q3 2020 and held it in 1 quarter.
  • Sio Capital Management's Quest Diagnostics position peaked at $8.59M in Q3 2020.
  • 812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Sio Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.